Gene Therapy Market – Table of Contents

Global Gene Therapy Market, By Type (Gene Silencing, Cell Replacement, Gene Augmentation), Vector (Viral Vectors, Non-Viral Vectors), Therapeutic Area (Neurology, Oncology, Hepatology), Delivery Method (In Vivo, Ex Vivo), Route of Administration (Intravenous, Other Routes of Administration), and Region – Industry Analysis and Forecast to 2030

1 Executive Summary

2 Market Introduction
    2.1 Definition
    2.2 Architecture
    2.3 Scope of the Study
    2.4 Related Stakeholders

3 Research Methodology
    3.1 Introduction
    3.2 Primary Research
        3.2.1 Key Insights
        3.2.2 Breakdown of Primary Interviews
    3.3 Secondary Research
        3.3.1 Important Sources
    3.4 Market Size Estimation Approaches
        3.4.1 Top-Down Approach
        3.4.2 Bottom-Up Approach
        3.4.3 Data Triangulation
    3.5 List of Assumptions

4 Market Dynamics
    4.1 Introduction
    4.2 Drivers
    4.3 Restraints
    4.4 Opportunities
    4.5 Challenges
    4.6 Porter’s Five Forces Model Analysis
    4.7 Value Chain Analysis
    4.8 Regulatory Landscape

5 Global Gene Therapy Market: Type
    5.1 Introduction
    5.2 Gene Silencing
    5.3 Cell Replacement
    5.4 Gene Augmentation
    5.5 Other Therapies

6 Global Gene Therapy Market: Vector
    6.1 Introduction
    6.2 Viral Vectors
        6.2.1 Retroviral Vectors
            6.2.1.1 Gamma Retroviral Vectors
            6.2.1.2 Lentiviral Vectors
        6.2.2 Adeno-Associated Viral Vectors
        6.2.3 Other Viral Vectors
    6.3 Non-Viral Vectors
        6.3.1 Oligonucleotides
        6.3.2 Other Non-Viral Vectors

7 Global Gene Therapy Market: Therapeutic Area
    7.1 Introduction
    7.2 Neurology
    7.3 Oncology
    7.4 Hepatology
    7.5 Other Therapeutic Areas

8 Global Gene Therapy Market: Delivery Method
    8.1 Introduction
    8.2 In Vivo
    8.3 Ex Vivo

9 Global Gene Therapy Market: Route of Administration
    9.1 Introduction
    9.2 Intravenous
    9.3 Other Routes of Administration

10 Global Gene Therapy Market: Regional Trends
    10.1 Introduction
    10.2 North America
        10.2.1 US
        10.2.2 Canada
    10.3 Europe
        10.3.1 Germany
        10.3.2 UK
        10.3.3 France
        10.3.4 Italy
        10.3.5 Spain
        10.3.6 Rest of Europe
    10.4 Asia-Pacific
        10.4.1 China
        10.4.2 India
        10.4.3 Japan
        10.4.4 South Korea
        10.4.5 Rest of Asia-Pacific
    10.5 Middle East and Africa
        10.5.1 GCC Countries
        10.5.2 South Africa
        10.5.3 Rest of Middle East and Africa
    10.6 Latin America
        10.6.1 Brazil
        10.6.2 Mexico
        10.6.3 Argentina
        10.6.4 Rest of Latin America

11 Competitive Landscape
    11.1 Introduction
    11.2 Vendor Evaluation Criteria
    11.3 Vendor Share Analysis, 2023
    11.4 Recent Developments, 2021-2023
        11.4.1 New Product Launches
        11.4.2 Partnerships
        11.4.3 Mergers or Acquisitions
        11.4.4 Business Expansions

12 Company Profiles
    12.1 Novartis AG
    12.2 Biogen Inc.
    12.3 Gilead Sciences, Inc.
    12.4 Bristol-Myers Squibb Company
    12.5 Sarepta Therapeutics, Inc.
    12.6 Amgen Inc.
    12.7 Alnylam Pharmaceuticals, Inc.
    12.8 Orchard Therapeutics plc
    12.9 Jazz Pharmaceuticals plc
    12.10 Uniqure N.V.
    12.11 Fhoffmann-La Roche AG
    12.12 Johnson & Johnson
    12.13 Bluebird Bio, Inc.
    12.14 Biomarin Pharmaceutical Inc.
    12.15 Sibiono Genetech Co.,Ltd.
    12.16 Krystal Biotech, Inc.
    12.17 Shanghai Sunway Biotech Co., Ltd.

13 Appendix
    13.1 Discussion Guide
    13.2 Customization Options
    13.3 Related Reports

List of Tables

Table 1 Global Gene Therapy Market: Type, 2023-2030 (USD Million)
Table 2 Global Gene Therapy Market Sales Volume: Type, 2023-2030 (NA)
Table 3 Global Gene Therapy Market: Vector, 2023-2030 (USD Million)
Table 4 Global Gene Therapy Market Sales Volume: Vector, 2023-2030 (NA)
Table 5 Global Gene Therapy Market: Viral Vector, 2023-2030 (USD Million)
Table 6 Global Gene Therapy Market Sales Volume: Viral Vector, 2023-2030 (NA)
Table 7 Global Gene Therapy Market: Non-Viral Vector, 2023-2030 (USD Million)
Table 8 Global Gene Therapy Market Sales Volume: Non-Viral Vector, 2023-2030 (NA)
Table 9 Global Gene Therapy Market: Therapeutic Area, 2023-2030 (USD Million)
Table 10 Global Gene Therapy Market Sales Volume: Therapeutic Area, 2023-2030 (NA)
Table 11 Global Gene Therapy Market: Delivery Method, 2023-2030 (USD Million)
Table 12 Global Gene Therapy Market Sales Volume: Delivery Method, 2023-2030 (NA)
Table 13 Global Gene Therapy Market: Route of Administration, 2023-2030 (USD Million)
Table 14 Global Gene Therapy Market Sales Volume: Route of Administration, 2023-2030 (NA)
Table 15 Global Gene Therapy Market: Region, 2023-2030 (USD Million)
Table 16 Global Gene Therapy Market Sales Volume: Region, 2023-2030 (NA)
Table 17 North America Gene Therapy Market: Country, 2023-2030 (USD Million)
Table 18 North America Gene Therapy Market Sales Volume: Country, 2023-2030 (NA)
Table 19 North America Gene Therapy Market: Type, 2023-2030 (USD Million)
Table 20 North America Gene Therapy Market Sales Volume: Type, 2023-2030 (NA)
Table 21 North America Gene Therapy Market: Vector, 2023-2030 (USD Million)
Table 22 North America Gene Therapy Market Sales Volume: Vector, 2023-2030 (NA)
Table 23 North America Gene Therapy Market: Viral Vector, 2023-2030 (USD Million)
Table 24 North America Gene Therapy Market Sales Volume: Viral Vector, 2023-2030 (NA)
Table 25 North America Gene Therapy Market: Non-Viral Vector, 2023-2030 (USD Million)
Table 26 North America Gene Therapy Market Sales Volume: Non-Viral Vector, 2023-2030 (NA)
Table 27 North America Gene Therapy Market: Therapeutic Area, 2023-2030 (USD Million)
Table 28 North America Gene Therapy Market Sales Volume: Therapeutic Area, 2023-2030 (NA)
Table 29 North America Gene Therapy Market: Delivery Method, 2023-2030 (USD Million)
Table 30 North America Gene Therapy Market Sales Volume: Delivery Method, 2023-2030 (NA)
Table 31 North America Gene Therapy Market: Route of Administration, 2023-2030 (USD Million)
Table 32 North America Gene Therapy Market Sales Volume: Route of Administration, 2023-2030 (NA)
Table 33 US Gene Therapy Market: Type, 2023-2030 (USD Million)
Table 34 US Gene Therapy Market Sales Volume: Type, 2023-2030 (NA)
Table 35 US Gene Therapy Market: Vector, 2023-2030 (USD Million)
Table 36 US Gene Therapy Market Sales Volume: Vector, 2023-2030 (NA)
Table 37 US Gene Therapy Market: Viral Vector, 2023-2030 (USD Million)
Table 38 US Gene Therapy Market Sales Volume: Viral Vector, 2023-2030 (NA)
Table 39 US Gene Therapy Market: Non-Viral Vector, 2023-2030 (USD Million)
Table 40 US Gene Therapy Market Sales Volume: Non-Viral Vector, 2023-2030 (NA)
Table 41 US Gene Therapy Market: Therapeutic Area, 2023-2030 (USD Million)
Table 42 US Gene Therapy Market Sales Volume: Therapeutic Area, 2023-2030 (NA)
Table 43 US Gene Therapy Market: Delivery Method, 2023-2030 (USD Million)
Table 44 US Gene Therapy Market Sales Volume: Delivery Method, 2023-2030 (NA)
Table 45 US Gene Therapy Market: Route of Administration, 2023-2030 (USD Million)
Table 46 US Gene Therapy Market Sales Volume: Route of Administration, 2023-2030 (NA)
Table 47 Canada Gene Therapy Market: Type, 2023-2030 (USD Million)
Table 48 Canada Gene Therapy Market Sales Volume: Type, 2023-2030 (NA)
Table 49 Canada Gene Therapy Market: Vector, 2023-2030 (USD Million)
Table 50 Canada Gene Therapy Market Sales Volume: Vector, 2023-2030 (NA)
Table 51 Canada Gene Therapy Market: Viral Vector, 2023-2030 (USD Million)
Table 52 Canada Gene Therapy Market Sales Volume: Viral Vector, 2023-2030 (NA)
Table 53 Canada Gene Therapy Market: Non-Viral Vector, 2023-2030 (USD Million)
Table 54 Canada Gene Therapy Market Sales Volume: Non-Viral Vector, 2023-2030 (NA)
Table 55 Canada Gene Therapy Market: Therapeutic Area, 2023-2030 (USD Million)
Table 56 Canada Gene Therapy Market Sales Volume: Therapeutic Area, 2023-2030 (NA)
Table 57 Canada Gene Therapy Market: Delivery Method, 2023-2030 (USD Million)
Table 58 Canada Gene Therapy Market Sales Volume: Delivery Method, 2023-2030 (NA)
Table 59 Canada Gene Therapy Market: Route of Administration, 2023-2030 (USD Million)
Table 60 Canada Gene Therapy Market Sales Volume: Route of Administration, 2023-2030 (NA)
Table 61 Europe Gene Therapy Market: Country, 2023-2030 (USD Million)
Table 62 Europe Gene Therapy Market Sales Volume: Country, 2023-2030 (NA)
Table 63 Europe Gene Therapy Market: Type, 2023-2030 (USD Million)
Table 64 Europe Gene Therapy Market Sales Volume: Type, 2023-2030 (NA)
Table 65 Europe Gene Therapy Market: Vector, 2023-2030 (USD Million)
Table 66 Europe Gene Therapy Market Sales Volume: Vector, 2023-2030 (NA)
Table 67 Europe Gene Therapy Market: Viral Vector, 2023-2030 (USD Million)
Table 68 Europe Gene Therapy Market Sales Volume: Viral Vector, 2023-2030 (NA)
Table 69 Europe Gene Therapy Market: Non-Viral Vector, 2023-2030 (USD Million)
Table 70 Europe Gene Therapy Market Sales Volume: Non-Viral Vector, 2023-2030 (NA)
Table 71 Europe Gene Therapy Market: Therapeutic Area, 2023-2030 (USD Million)
Table 72 Europe Gene Therapy Market Sales Volume: Therapeutic Area, 2023-2030 (NA)
Table 73 Europe Gene Therapy Market: Delivery Method, 2023-2030 (USD Million)
Table 74 Europe Gene Therapy Market Sales Volume: Delivery Method, 2023-2030 (NA)
Table 75 Europe Gene Therapy Market: Route of Administration, 2023-2030 (USD Million)
Table 76 Europe Gene Therapy Market Sales Volume: Route of Administration, 2023-2030 (NA)
Table 77 Germany Gene Therapy Market: Type, 2023-2030 (USD Million)
Table 78 Germany Gene Therapy Market Sales Volume: Type, 2023-2030 (NA)
Table 79 Germany Gene Therapy Market: Vector, 2023-2030 (USD Million)
Table 80 Germany Gene Therapy Market Sales Volume: Vector, 2023-2030 (NA)
Table 81 Germany Gene Therapy Market: Viral Vector, 2023-2030 (USD Million)
Table 82 Germany Gene Therapy Market Sales Volume: Viral Vector, 2023-2030 (NA)
Table 83 Germany Gene Therapy Market: Non-Viral Vector, 2023-2030 (USD Million)
Table 84 Germany Gene Therapy Market Sales Volume: Non-Viral Vector, 2023-2030 (NA)
Table 85 Germany Gene Therapy Market: Therapeutic Area, 2023-2030 (USD Million)
Table 86 Germany Gene Therapy Market Sales Volume: Therapeutic Area, 2023-2030 (NA)
Table 87 Germany Gene Therapy Market: Delivery Method, 2023-2030 (USD Million)
Table 88 Germany Gene Therapy Market Sales Volume: Delivery Method, 2023-2030 (NA)
Table 89 Germany Gene Therapy Market: Route of Administration, 2023-2030 (USD Million)
Table 90 Germany Gene Therapy Market Sales Volume: Route of Administration, 2023-2030 (NA)
Table 91 UK Gene Therapy Market: Type, 2023-2030 (USD Million)
Table 92 UK Gene Therapy Market Sales Volume: Type, 2023-2030 (NA)
Table 93 UK Gene Therapy Market: Vector, 2023-2030 (USD Million)
Table 94 UK Gene Therapy Market Sales Volume: Vector, 2023-2030 (NA)
Table 95 UK Gene Therapy Market: Viral Vector, 2023-2030 (USD Million)
Table 96 UK Gene Therapy Market Sales Volume: Viral Vector, 2023-2030 (NA)
Table 97 UK Gene Therapy Market: Non-Viral Vector, 2023-2030 (USD Million)
Table 98 UK Gene Therapy Market Sales Volume: Non-Viral Vector, 2023-2030 (NA)
Table 99 UK Gene Therapy Market: Therapeutic Area, 2023-2030 (USD Million)
Table 100 UK Gene Therapy Market Sales Volume: Therapeutic Area, 2023-2030 (NA)
Table 101 UK Gene Therapy Market: Delivery Method, 2023-2030 (USD Million)
Table 102 UK Gene Therapy Market Sales Volume: Delivery Method, 2023-2030 (NA)
Table 103 UK Gene Therapy Market: Route of Administration, 2023-2030 (USD Million)
Table 104 UK Gene Therapy Market Sales Volume: Route of Administration, 2023-2030 (NA)
Table 105 France Gene Therapy Market: Type, 2023-2030 (USD Million)
Table 106 France Gene Therapy Market Sales Volume: Type, 2023-2030 (NA)
Table 107 France Gene Therapy Market: Vector, 2023-2030 (USD Million)
Table 108 France Gene Therapy Market Sales Volume: Vector, 2023-2030 (NA)
Table 109 France Gene Therapy Market: Viral Vector, 2023-2030 (USD Million)
Table 110 France Gene Therapy Market Sales Volume: Viral Vector, 2023-2030 (NA)
Table 111 France Gene Therapy Market: Non-Viral Vector, 2023-2030 (USD Million)
Table 112 France Gene Therapy Market Sales Volume: Non-Viral Vector, 2023-2030 (NA)
Table 113 France Gene Therapy Market: Therapeutic Area, 2023-2030 (USD Million)
Table 114 France Gene Therapy Market Sales Volume: Therapeutic Area, 2023-2030 (NA)
Table 115 France Gene Therapy Market: Delivery Method, 2023-2030 (USD Million)
Table 116 France Gene Therapy Market Sales Volume: Delivery Method, 2023-2030 (NA)
Table 117 France Gene Therapy Market: Route of Administration, 2023-2030 (USD Million)
Table 118 France Gene Therapy Market Sales Volume: Route of Administration, 2023-2030 (NA)
Table 119 Italy Gene Therapy Market: Type, 2023-2030 (USD Million)
Table 120 Italy Gene Therapy Market Sales Volume: Type, 2023-2030 (NA)
Table 121 Italy Gene Therapy Market: Vector, 2023-2030 (USD Million)
Table 122 Italy Gene Therapy Market Sales Volume: Vector, 2023-2030 (NA)
Table 123 Italy Gene Therapy Market: Viral Vector, 2023-2030 (USD Million)
Table 124 Italy Gene Therapy Market Sales Volume: Viral Vector, 2023-2030 (NA)
Table 125 Italy Gene Therapy Market: Non-Viral Vector, 2023-2030 (USD Million)
Table 126 Italy Gene Therapy Market Sales Volume: Non-Viral Vector, 2023-2030 (NA)
Table 127 Italy Gene Therapy Market: Therapeutic Area, 2023-2030 (USD Million)
Table 128 Italy Gene Therapy Market Sales Volume: Therapeutic Area, 2023-2030 (NA)
Table 129 Italy Gene Therapy Market: Delivery Method, 2023-2030 (USD Million)
Table 130 Italy Gene Therapy Market Sales Volume: Delivery Method, 2023-2030 (NA)
Table 131 Italy Gene Therapy Market: Route of Administration, 2023-2030 (USD Million)
Table 132 Italy Gene Therapy Market Sales Volume: Route of Administration, 2023-2030 (NA)
Table 133 Spain Gene Therapy Market: Type, 2023-2030 (USD Million)
Table 134 Spain Gene Therapy Market Sales Volume: Type, 2023-2030 (NA)
Table 135 Spain Gene Therapy Market: Vector, 2023-2030 (USD Million)
Table 136 Spain Gene Therapy Market Sales Volume: Vector, 2023-2030 (NA)
Table 137 Spain Gene Therapy Market: Viral Vector, 2023-2030 (USD Million)
Table 138 Spain Gene Therapy Market Sales Volume: Viral Vector, 2023-2030 (NA)
Table 139 Spain Gene Therapy Market: Non-Viral Vector, 2023-2030 (USD Million)
Table 140 Spain Gene Therapy Market Sales Volume: Non-Viral Vector, 2023-2030 (NA)
Table 141 Spain Gene Therapy Market: Therapeutic Area, 2023-2030 (USD Million)
Table 142 Spain Gene Therapy Market Sales Volume: Therapeutic Area, 2023-2030 (NA)
Table 143 Spain Gene Therapy Market: Delivery Method, 2023-2030 (USD Million)
Table 144 Spain Gene Therapy Market Sales Volume: Delivery Method, 2023-2030 (NA)
Table 145 Spain Gene Therapy Market: Route of Administration, 2023-2030 (USD Million)
Table 146 Spain Gene Therapy Market Sales Volume: Route of Administration, 2023-2030 (NA)
Table 147 Rest of Europe Gene Therapy Market: Type, 2023-2030 (USD Million)
Table 148 Rest of Europe Gene Therapy Market Sales Volume: Type, 2023-2030 (NA)
Table 149 Rest of Europe Gene Therapy Market: Vector, 2023-2030 (USD Million)
Table 150 Rest of Europe Gene Therapy Market Sales Volume: Vector, 2023-2030 (NA)
Table 151 Rest of Europe Gene Therapy Market: Viral Vector, 2023-2030 (USD Million)
Table 152 Rest of Europe Gene Therapy Market Sales Volume: Viral Vector, 2023-2030 (NA)
Table 153 Rest of Europe Gene Therapy Market: Non-Viral Vector, 2023-2030 (USD Million)
Table 154 Rest of Europe Gene Therapy Market Sales Volume: Non-Viral Vector, 2023-2030 (NA)
Table 155 Rest of Europe Gene Therapy Market: Therapeutic Area, 2023-2030 (USD Million)
Table 156 Rest of Europe Gene Therapy Market Sales Volume: Therapeutic Area, 2023-2030 (NA)
Table 157 Rest of Europe Gene Therapy Market: Delivery Method, 2023-2030 (USD Million)
Table 158 Rest of Europe Gene Therapy Market Sales Volume: Delivery Method, 2023-2030 (NA)
Table 159 Rest of Europe Gene Therapy Market: Route of Administration, 2023-2030 (USD Million)
Table 160 Rest of Europe Gene Therapy Market Sales Volume: Route of Administration, 2023-2030 (NA)
Table 161 Asia Pacific Gene Therapy Market: Country, 2023-2030 (USD Million)
Table 162 Asia Pacific Gene Therapy Market Sales Volume: Country, 2023-2030 (NA)
Table 163 Asia Pacific Gene Therapy Market: Type, 2023-2030 (USD Million)
Table 164 Asia Pacific Gene Therapy Market Sales Volume: Type, 2023-2030 (NA)
Table 165 Asia Pacific Gene Therapy Market: Vector, 2023-2030 (USD Million)
Table 166 Asia Pacific Gene Therapy Market Sales Volume: Vector, 2023-2030 (NA)
Table 167 Asia Pacific Gene Therapy Market: Viral Vector, 2023-2030 (USD Million)
Table 168 Asia Pacific Gene Therapy Market Sales Volume: Viral Vector, 2023-2030 (NA)
Table 169 Asia Pacific Gene Therapy Market: Non-Viral Vector, 2023-2030 (USD Million)
Table 170 Asia Pacific Gene Therapy Market Sales Volume: Non-Viral Vector, 2023-2030 (NA)
Table 171 Asia Pacific Gene Therapy Market: Therapeutic Area, 2023-2030 (USD Million)
Table 172 Asia Pacific Gene Therapy Market Sales Volume: Therapeutic Area, 2023-2030 (NA)
Table 173 Asia Pacific Gene Therapy Market: Delivery Method, 2023-2030 (USD Million)
Table 174 Asia Pacific Gene Therapy Market Sales Volume: Delivery Method, 2023-2030 (NA)
Table 175 Asia Pacific Gene Therapy Market: Route of Administration, 2023-2030 (USD Million)
Table 176 Asia Pacific Gene Therapy Market Sales Volume: Route of Administration, 2023-2030 (NA)
Table 177 China Gene Therapy Market: Type, 2023-2030 (USD Million)
Table 178 China Gene Therapy Market Sales Volume: Type, 2023-2030 (NA)
Table 179 China Gene Therapy Market: Vector, 2023-2030 (USD Million)
Table 180 China Gene Therapy Market Sales Volume: Vector, 2023-2030 (NA)
Table 181 China Gene Therapy Market: Viral Vector, 2023-2030 (USD Million)
Table 182 China Gene Therapy Market Sales Volume: Viral Vector, 2023-2030 (NA)
Table 183 China Gene Therapy Market: Non-Viral Vector, 2023-2030 (USD Million)
Table 184 China Gene Therapy Market Sales Volume: Non-Viral Vector, 2023-2030 (NA)
Table 185 China Gene Therapy Market: Therapeutic Area, 2023-2030 (USD Million)
Table 186 China Gene Therapy Market Sales Volume: Therapeutic Area, 2023-2030 (NA)
Table 187 China Gene Therapy Market: Delivery Method, 2023-2030 (USD Million)
Table 188 China Gene Therapy Market Sales Volume: Delivery Method, 2023-2030 (NA)
Table 189 China Gene Therapy Market: Route of Administration, 2023-2030 (USD Million)
Table 190 China Gene Therapy Market Sales Volume: Route of Administration, 2023-2030 (NA)
Table 191 India Gene Therapy Market: Type, 2023-2030 (USD Million)
Table 192 India Gene Therapy Market Sales Volume: Type, 2023-2030 (NA)
Table 193 India Gene Therapy Market: Vector, 2023-2030 (USD Million)
Table 194 India Gene Therapy Market Sales Volume: Vector, 2023-2030 (NA)
Table 195 India Gene Therapy Market: Viral Vector, 2023-2030 (USD Million)
Table 196 India Gene Therapy Market Sales Volume: Viral Vector, 2023-2030 (NA)
Table 197 India Gene Therapy Market: Non-Viral Vector, 2023-2030 (USD Million)
Table 198 India Gene Therapy Market Sales Volume: Non-Viral Vector, 2023-2030 (NA)
Table 199 India Gene Therapy Market: Therapeutic Area, 2023-2030 (USD Million)
Table 200 India Gene Therapy Market Sales Volume: Therapeutic Area, 2023-2030 (NA)
Table 201 India Gene Therapy Market: Delivery Method, 2023-2030 (USD Million)
Table 202 India Gene Therapy Market Sales Volume: Delivery Method, 2023-2030 (NA)
Table 203 India Gene Therapy Market: Route of Administration, 2023-2030 (USD Million)
Table 204 India Gene Therapy Market Sales Volume: Route of Administration, 2023-2030 (NA)
Table 205 Japan Gene Therapy Market: Type, 2023-2030 (USD Million)
Table 206 Japan Gene Therapy Market Sales Volume: Type, 2023-2030 (NA)
Table 207 Japan Gene Therapy Market: Vector, 2023-2030 (USD Million)
Table 208 Japan Gene Therapy Market Sales Volume: Vector, 2023-2030 (NA)
Table 209 Japan Gene Therapy Market: Viral Vector, 2023-2030 (USD Million)
Table 210 Japan Gene Therapy Market Sales Volume: Viral Vector, 2023-2030 (NA)
Table 211 Japan Gene Therapy Market: Non-Viral Vector, 2023-2030 (USD Million)
Table 212 Japan Gene Therapy Market Sales Volume: Non-Viral Vector, 2023-2030 (NA)
Table 213 Japan Gene Therapy Market: Therapeutic Area, 2023-2030 (USD Million)
Table 214 Japan Gene Therapy Market Sales Volume: Therapeutic Area, 2023-2030 (NA)
Table 215 Japan Gene Therapy Market: Delivery Method, 2023-2030 (USD Million)
Table 216 Japan Gene Therapy Market Sales Volume: Delivery Method, 2023-2030 (NA)
Table 217 Japan Gene Therapy Market: Route of Administration, 2023-2030 (USD Million)
Table 218 Japan Gene Therapy Market Sales Volume: Route of Administration, 2023-2030 (NA)
Table 219 South Korea Gene Therapy Market: Type, 2023-2030 (USD Million)
Table 220 South Korea Gene Therapy Market Sales Volume: Type, 2023-2030 (NA)
Table 221 South Korea Gene Therapy Market: Vector, 2023-2030 (USD Million)
Table 222 South Korea Gene Therapy Market Sales Volume: Vector, 2023-2030 (NA)
Table 223 South Korea Gene Therapy Market: Viral Vector, 2023-2030 (USD Million)
Table 224 South Korea Gene Therapy Market Sales Volume: Viral Vector, 2023-2030 (NA)
Table 225 South Korea Gene Therapy Market: Non-Viral Vector, 2023-2030 (USD Million)
Table 226 South Korea Gene Therapy Market Sales Volume: Non-Viral Vector, 2023-2030 (NA)
Table 227 South Korea Gene Therapy Market: Therapeutic Area, 2023-2030 (USD Million)
Table 228 South Korea Gene Therapy Market Sales Volume: Therapeutic Area, 2023-2030 (NA)
Table 229 South Korea Gene Therapy Market: Delivery Method, 2023-2030 (USD Million)
Table 230 South Korea Gene Therapy Market Sales Volume: Delivery Method, 2023-2030 (NA)
Table 231 South Korea Gene Therapy Market: Route of Administration, 2023-2030 (USD Million)
Table 232 South Korea Gene Therapy Market Sales Volume: Route of Administration, 2023-2030 (NA)
Table 233 Rest of Asia Pacific Gene Therapy Market: Type, 2023-2030 (USD Million)
Table 234 Rest of Asia Pacific Gene Therapy Market Sales Volume: Type, 2023-2030 (NA)
Table 235 Rest of Asia Pacific Gene Therapy Market: Vector, 2023-2030 (USD Million)
Table 236 Rest of Asia Pacific Gene Therapy Market Sales Volume: Vector, 2023-2030 (NA)
Table 237 Rest of Asia Pacific Gene Therapy Market: Viral Vector, 2023-2030 (USD Million)
Table 238 Rest of Asia Pacific Gene Therapy Market Sales Volume: Viral Vector, 2023-2030 (NA)
Table 239 Rest of Asia Pacific Gene Therapy Market: Non-Viral Vector, 2023-2030 (USD Million)
Table 240 Rest of Asia Pacific Gene Therapy Market Sales Volume: Non-Viral Vector, 2023-2030 (NA)
Table 241 Rest of Asia Pacific Gene Therapy Market: Therapeutic Area, 2023-2030 (USD Million)
Table 242 Rest of Asia Pacific Gene Therapy Market Sales Volume: Therapeutic Area, 2023-2030 (NA)
Table 243 Rest of Asia Pacific Gene Therapy Market: Delivery Method, 2023-2030 (USD Million)
Table 244 Rest of Asia Pacific Gene Therapy Market Sales Volume: Delivery Method, 2023-2030 (NA)
Table 245 Rest of Asia Pacific Gene Therapy Market: Route of Administration, 2023-2030 (USD Million)
Table 246 Rest of Asia Pacific Gene Therapy Market Sales Volume: Route of Administration, 2023-2030 (NA)
Table 247 Middle East and Africa Gene Therapy Market: Country, 2023-2030 (USD Million)
Table 248 Middle East and Africa Gene Therapy Market Sales Volume: Country, 2023-2030 (NA)
Table 249 Middle East and Africa Gene Therapy Market: Type, 2023-2030 (USD Million)
Table 250 Middle East and Africa Gene Therapy Market Sales Volume: Type, 2023-2030 (NA)
Table 251 Middle East and Africa Gene Therapy Market: Vector, 2023-2030 (USD Million)
Table 252 Middle East and Africa Gene Therapy Market Sales Volume: Vector, 2023-2030 (NA)
Table 253 Middle East and Africa Gene Therapy Market: Viral Vector, 2023-2030 (USD Million)
Table 254 Middle East and Africa Gene Therapy Market Sales Volume: Viral Vector, 2023-2030 (NA)
Table 255 Middle East and Africa Gene Therapy Market: Non-Viral Vector, 2023-2030 (USD Million)
Table 256 Middle East and Africa Gene Therapy Market Sales Volume: Non-Viral Vector, 2023-2030 (NA)
Table 257 Middle East and Africa Gene Therapy Market: Therapeutic Area, 2023-2030 (USD Million)
Table 258 Middle East and Africa Gene Therapy Market Sales Volume: Therapeutic Area, 2023-2030 (NA)
Table 259 Middle East and Africa Gene Therapy Market: Delivery Method, 2023-2030 (USD Million)
Table 260 Middle East and Africa Gene Therapy Market Sales Volume: Delivery Method, 2023-2030 (NA)
Table 261 Middle East and Africa Gene Therapy Market: Route of Administration, 2023-2030 (USD Million)
Table 262 Middle East and Africa Gene Therapy Market Sales Volume: Route of Administration, 2023-2030 (NA)
Table 263 GCC Countries Gene Therapy Market: Type, 2023-2030 (USD Million)
Table 264 GCC Countries Gene Therapy Market Sales Volume: Type, 2023-2030 (NA)
Table 265 GCC Countries Gene Therapy Market: Vector, 2023-2030 (USD Million)
Table 266 GCC Countries Gene Therapy Market Sales Volume: Vector, 2023-2030 (NA)
Table 267 GCC Countries Gene Therapy Market: Viral Vector, 2023-2030 (USD Million)
Table 268 GCC Countries Gene Therapy Market Sales Volume: Viral Vector, 2023-2030 (NA)
Table 269 GCC Countries Gene Therapy Market: Non-Viral Vector, 2023-2030 (USD Million)
Table 270 GCC Countries Gene Therapy Market Sales Volume: Non-Viral Vector, 2023-2030 (NA)
Table 271 GCC Countries Gene Therapy Market: Therapeutic Area, 2023-2030 (USD Million)
Table 272 GCC Countries Gene Therapy Market Sales Volume: Therapeutic Area, 2023-2030 (NA)
Table 273 GCC Countries Gene Therapy Market: Delivery Method, 2023-2030 (USD Million)
Table 274 GCC Countries Gene Therapy Market Sales Volume: Delivery Method, 2023-2030 (NA)
Table 275 GCC Countries Gene Therapy Market: Route of Administration, 2023-2030 (USD Million)
Table 276 GCC Countries Gene Therapy Market Sales Volume: Route of Administration, 2023-2030 (NA)
Table 277 South Africa Gene Therapy Market: Type, 2023-2030 (USD Million)
Table 278 South Africa Gene Therapy Market Sales Volume: Type, 2023-2030 (NA)
Table 279 South Africa Gene Therapy Market: Vector, 2023-2030 (USD Million)
Table 280 South Africa Gene Therapy Market Sales Volume: Vector, 2023-2030 (NA)
Table 281 South Africa Gene Therapy Market: Viral Vector, 2023-2030 (USD Million)
Table 282 South Africa Gene Therapy Market Sales Volume: Viral Vector, 2023-2030 (NA)
Table 283 South Africa Gene Therapy Market: Non-Viral Vector, 2023-2030 (USD Million)
Table 284 South Africa Gene Therapy Market Sales Volume: Non-Viral Vector, 2023-2030 (NA)
Table 285 South Africa Gene Therapy Market: Therapeutic Area, 2023-2030 (USD Million)
Table 286 South Africa Gene Therapy Market Sales Volume: Therapeutic Area, 2023-2030 (NA)
Table 287 South Africa Gene Therapy Market: Delivery Method, 2023-2030 (USD Million)
Table 288 South Africa Gene Therapy Market Sales Volume: Delivery Method, 2023-2030 (NA)
Table 289 South Africa Gene Therapy Market: Route of Administration, 2023-2030 (USD Million)
Table 290 South Africa Gene Therapy Market Sales Volume: Route of Administration, 2023-2030 (NA)
Table 291 Rest of Middle East and Africa Gene Therapy Market: Type, 2023-2030 (USD Million)
Table 292 Rest of Middle East and Africa Gene Therapy Market Sales Volume: Type, 2023-2030 (NA)
Table 293 Rest of Middle East and Africa Gene Therapy Market: Vector, 2023-2030 (USD Million)
Table 294 Rest of Middle East and Africa Gene Therapy Market Sales Volume: Vector, 2023-2030 (NA)
Table 295 Rest of Middle East and Africa Gene Therapy Market: Viral Vector, 2023-2030 (USD Million)
Table 296 Rest of Middle East and Africa Gene Therapy Market Sales Volume: Viral Vector, 2023-2030 (NA)
Table 297 Rest of Middle East and Africa Gene Therapy Market: Non-Viral Vector, 2023-2030 (USD Million)
Table 298 Rest of Middle East and Africa Gene Therapy Market Sales Volume: Non-Viral Vector, 2023-2030 (NA)
Table 299 Rest of Middle East and Africa Gene Therapy Market: Therapeutic Area, 2023-2030 (USD Million)
Table 300 Rest of Middle East and Africa Gene Therapy Market Sales Volume: Therapeutic Area, 2023-2030 (NA)
Table 301 Rest of Middle East and Africa Gene Therapy Market: Delivery Method, 2023-2030 (USD Million)
Table 302 Rest of Middle East and Africa Gene Therapy Market Sales Volume: Delivery Method, 2023-2030 (NA)
Table 303 Rest of Middle East and Africa Gene Therapy Market: Route of Administration, 2023-2030 (USD Million)
Table 304 Rest of Middle East and Africa Gene Therapy Market Sales Volume: Route of Administration, 2023-2030 (NA)
Table 305 Latin America Gene Therapy Market: Country, 2023-2030 (USD Million)
Table 306 Latin America Gene Therapy Market Sales Volume: Country, 2023-2030 (NA)
Table 307 Latin America Gene Therapy Market: Type, 2023-2030 (USD Million)
Table 308 Latin America Gene Therapy Market Sales Volume: Type, 2023-2030 (NA)
Table 309 Latin America Gene Therapy Market: Vector, 2023-2030 (USD Million)
Table 310 Latin America Gene Therapy Market Sales Volume: Vector, 2023-2030 (NA)
Table 311 Latin America Gene Therapy Market: Viral Vector, 2023-2030 (USD Million)
Table 312 Latin America Gene Therapy Market Sales Volume: Viral Vector, 2023-2030 (NA)
Table 313 Latin America Gene Therapy Market: Non-Viral Vector, 2023-2030 (USD Million)
Table 314 Latin America Gene Therapy Market Sales Volume: Non-Viral Vector, 2023-2030 (NA)
Table 315 Latin America Gene Therapy Market: Therapeutic Area, 2023-2030 (USD Million)
Table 316 Latin America Gene Therapy Market Sales Volume: Therapeutic Area, 2023-2030 (NA)
Table 317 Latin America Gene Therapy Market: Delivery Method, 2023-2030 (USD Million)
Table 318 Latin America Gene Therapy Market Sales Volume: Delivery Method, 2023-2030 (NA)
Table 319 Latin America Gene Therapy Market: Route of Administration, 2023-2030 (USD Million)
Table 320 Latin America Gene Therapy Market Sales Volume: Route of Administration, 2023-2030 (NA)
Table 321 Brazil Gene Therapy Market: Type, 2023-2030 (USD Million)
Table 322 Brazil Gene Therapy Market Sales Volume: Type, 2023-2030 (NA)
Table 323 Brazil Gene Therapy Market: Vector, 2023-2030 (USD Million)
Table 324 Brazil Gene Therapy Market Sales Volume: Vector, 2023-2030 (NA)
Table 325 Brazil Gene Therapy Market: Viral Vector, 2023-2030 (USD Million)
Table 326 Brazil Gene Therapy Market Sales Volume: Viral Vector, 2023-2030 (NA)
Table 327 Brazil Gene Therapy Market: Non-Viral Vector, 2023-2030 (USD Million)
Table 328 Brazil Gene Therapy Market Sales Volume: Non-Viral Vector, 2023-2030 (NA)
Table 329 Brazil Gene Therapy Market: Therapeutic Area, 2023-2030 (USD Million)
Table 330 Brazil Gene Therapy Market Sales Volume: Therapeutic Area, 2023-2030 (NA)
Table 331 Brazil Gene Therapy Market: Delivery Method, 2023-2030 (USD Million)
Table 332 Brazil Gene Therapy Market Sales Volume: Delivery Method, 2023-2030 (NA)
Table 333 Brazil Gene Therapy Market: Route of Administration, 2023-2030 (USD Million)
Table 334 Brazil Gene Therapy Market Sales Volume: Route of Administration, 2023-2030 (NA)
Table 335 Mexico Gene Therapy Market: Type, 2023-2030 (USD Million)
Table 336 Mexico Gene Therapy Market Sales Volume: Type, 2023-2030 (NA)
Table 337 Mexico Gene Therapy Market: Vector, 2023-2030 (USD Million)
Table 338 Mexico Gene Therapy Market Sales Volume: Vector, 2023-2030 (NA)
Table 339 Mexico Gene Therapy Market: Viral Vector, 2023-2030 (USD Million)
Table 340 Mexico Gene Therapy Market Sales Volume: Viral Vector, 2023-2030 (NA)
Table 341 Mexico Gene Therapy Market: Non-Viral Vector, 2023-2030 (USD Million)
Table 342 Mexico Gene Therapy Market Sales Volume: Non-Viral Vector, 2023-2030 (NA)
Table 343 Mexico Gene Therapy Market: Therapeutic Area, 2023-2030 (USD Million)
Table 344 Mexico Gene Therapy Market Sales Volume: Therapeutic Area, 2023-2030 (NA)
Table 345 Mexico Gene Therapy Market: Delivery Method, 2023-2030 (USD Million)
Table 346 Mexico Gene Therapy Market Sales Volume: Delivery Method, 2023-2030 (NA)
Table 347 Mexico Gene Therapy Market: Route of Administration, 2023-2030 (USD Million)
Table 348 Mexico Gene Therapy Market Sales Volume: Route of Administration, 2023-2030 (NA)
Table 349 Argentina Gene Therapy Market: Type, 2023-2030 (USD Million)
Table 350 Argentina Gene Therapy Market Sales Volume: Type, 2023-2030 (NA)
Table 351 Argentina Gene Therapy Market: Vector, 2023-2030 (USD Million)
Table 352 Argentina Gene Therapy Market Sales Volume: Vector, 2023-2030 (NA)
Table 353 Argentina Gene Therapy Market: Viral Vector, 2023-2030 (USD Million)
Table 354 Argentina Gene Therapy Market Sales Volume: Viral Vector, 2023-2030 (NA)
Table 355 Argentina Gene Therapy Market: Non-Viral Vector, 2023-2030 (USD Million)
Table 356 Argentina Gene Therapy Market Sales Volume: Non-Viral Vector, 2023-2030 (NA)
Table 357 Argentina Gene Therapy Market: Therapeutic Area, 2023-2030 (USD Million)
Table 358 Argentina Gene Therapy Market Sales Volume: Therapeutic Area, 2023-2030 (NA)
Table 359 Argentina Gene Therapy Market: Delivery Method, 2023-2030 (USD Million)
Table 360 Argentina Gene Therapy Market Sales Volume: Delivery Method, 2023-2030 (NA)
Table 361 Argentina Gene Therapy Market: Route of Administration, 2023-2030 (USD Million)
Table 362 Argentina Gene Therapy Market Sales Volume: Route of Administration, 2023-2030 (NA)
Table 363 Rest of Latin America Gene Therapy Market: Type, 2023-2030 (USD Million)
Table 364 Rest of Latin America Gene Therapy Market Sales Volume: Type, 2023-2030 (NA)
Table 365 Rest of Latin America Gene Therapy Market: Vector, 2023-2030 (USD Million)
Table 366 Rest of Latin America Gene Therapy Market Sales Volume: Vector, 2023-2030 (NA)
Table 367 Rest of Latin America Gene Therapy Market: Viral Vector, 2023-2030 (USD Million)
Table 368 Rest of Latin America Gene Therapy Market Sales Volume: Viral Vector, 2023-2030 (NA)
Table 369 Rest of Latin America Gene Therapy Market: Non-Viral Vector, 2023-2030 (USD Million)
Table 370 Rest of Latin America Gene Therapy Market Sales Volume: Non-Viral Vector, 2023-2030 (NA)
Table 371 Rest of Latin America Gene Therapy Market: Therapeutic Area, 2023-2030 (USD Million)
Table 372 Rest of Latin America Gene Therapy Market Sales Volume: Therapeutic Area, 2023-2030 (NA)
Table 373 Rest of Latin America Gene Therapy Market: Delivery Method, 2023-2030 (USD Million)
Table 374 Rest of Latin America Gene Therapy Market Sales Volume: Delivery Method, 2023-2030 (NA)
Table 375 Rest of Latin America Gene Therapy Market: Route of Administration, 2023-2030 (USD Million)
Table 376 Rest of Latin America Gene Therapy Market Sales Volume: Route of Administration, 2023-2030 (NA)

List of Figures

Figure 1 Global Gene Therapy Market: Market Segmentation
Figure 2 Global Gene Therapy Market: Research Methodology
Figure 3 Breakdown of Primary Interviews
Figure 4 Top Down Approach
Figure 5 Bottom Up Approach
Figure 6 Data Triangulation
Figure 7 Global Gene Therapy Market: Drivers, Restraints, Opportunities, and Challenges
Figure 8 Global Gene Therapy Market: Porter’s Five Forces Model Analysis
Figure 9 Global Gene Therapy Market: Value Chain Analysis
Figure 10 Global Gene Therapy Market Share Analysis: Type, 2023 and 2030
Figure 11 Global Gene Therapy Market Share Analysis: Vector, 2023 and 2030
Figure 12 Global Gene Therapy Market Share Analysis: Viral Vector, 2023 and 2030
Figure 13 Global Gene Therapy Market Share Analysis: Non-Viral Vector, 2023 and 2030
Figure 14 Global Gene Therapy Market Share Analysis: Therapeutic Area, 2023 and 2030
Figure 15 Global Gene Therapy Market Share Analysis: Delivery Method, 2023 and 2030
Figure 16 Global Gene Therapy Market Share Analysis: Route of Administration, 2023 and 2030
Figure 17 Global Gene Therapy Market Share Analysis: Region, 2023 and 2030
Figure 18 North America Gene Therapy Market Share Analysis: Country, 2023 and 2030
Figure 19 North America Gene Therapy Market Share Analysis: Type, 2023 and 2030
Figure 20 North America Gene Therapy Market Share Analysis: Vector, 2023 and 2030
Figure 21 North America Gene Therapy Market Share Analysis: Viral Vector, 2023 and 2030
Figure 22 North America Gene Therapy Market Share Analysis: Non-Viral Vector, 2023 and 2030
Figure 23 North America Gene Therapy Market Share Analysis: Therapeutic Area, 2023 and 2030
Figure 24 North America Gene Therapy Market Share Analysis: Delivery Method, 2023 and 2030
Figure 25 North America Gene Therapy Market Share Analysis: Route of Administration, 2023 and 2030
Figure 26 Europe Gene Therapy Market Share Analysis: Country, 2023 and 2030
Figure 27 Europe Gene Therapy Market Share Analysis: Type, 2023 and 2030
Figure 28 Europe Gene Therapy Market Share Analysis: Vector, 2023 and 2030
Figure 29 Europe Gene Therapy Market Share Analysis: Viral Vector, 2023 and 2030
Figure 30 Europe Gene Therapy Market Share Analysis: Non-Viral Vector, 2023 and 2030
Figure 31 Europe Gene Therapy Market Share Analysis: Therapeutic Area, 2023 and 2030
Figure 32 Europe Gene Therapy Market Share Analysis: Delivery Method, 2023 and 2030
Figure 33 Europe Gene Therapy Market Share Analysis: Route of Administration, 2023 and 2030
Figure 34 Asia Pacific Gene Therapy Market Share Analysis: Country, 2023 and 2030
Figure 35 Asia Pacific Gene Therapy Market Share Analysis: Type, 2023 and 2030
Figure 36 Asia Pacific Gene Therapy Market Share Analysis: Vector, 2023 and 2030
Figure 37 Asia Pacific Gene Therapy Market Share Analysis: Viral Vector, 2023 and 2030
Figure 38 Asia Pacific Gene Therapy Market Share Analysis: Non-Viral Vector, 2023 and 2030
Figure 39 Asia Pacific Gene Therapy Market Share Analysis: Therapeutic Area, 2023 and 2030
Figure 40 Asia Pacific Gene Therapy Market Share Analysis: Delivery Method, 2023 and 2030
Figure 41 Asia Pacific Gene Therapy Market Share Analysis: Route of Administration, 2023 and 2030
Figure 42 Middle East and Africa Gene Therapy Market Share Analysis: Type, 2023 and 2030
Figure 43 Middle East and Africa Gene Therapy Market Share Analysis: Vector, 2023 and 2030
Figure 44 Middle East and Africa Gene Therapy Market Share Analysis: Viral Vector, 2023 and 2030
Figure 45 Middle East and Africa Gene Therapy Market Share Analysis: Non-Viral Vector, 2023 and 2030
Figure 46 Middle East and Africa Gene Therapy Market Share Analysis: Therapeutic Area, 2023 and 2030
Figure 47 Middle East and Africa Gene Therapy Market Share Analysis: Delivery Method, 2023 and 2030
Figure 48 Middle East and Africa Gene Therapy Market Share Analysis: Route of Administration, 2023 and 2030
Figure 49 Latin America Gene Therapy Market Share Analysis: Type, 2023 and 2030
Figure 50 Latin America Gene Therapy Market Share Analysis: Vector, 2023 and 2030
Figure 51 Latin America Gene Therapy Market Share Analysis: Viral Vector, 2023 and 2030
Figure 52 Latin America Gene Therapy Market Share Analysis: Non-Viral Vector, 2023 and 2030
Figure 53 Latin America Gene Therapy Market Share Analysis: Therapeutic Area, 2023 and 2030
Figure 54 Latin America Gene Therapy Market Share Analysis: Delivery Method, 2023 and 2030
Figure 55 Latin America Gene Therapy Market Share Analysis: Route of Administration, 2023 and 2030
Figure 56 Global Gene Therapy Market: Competitive Benchmarking
Figure 57 Global Gene Therapy Market: Vendor Share Analysis, 2023

PRICE

ASK FOR FREE SAMPLE REPORT